GlaxoSmithKline Overview

  • Founded
  • 2000
Founded
  • Status
  • Public
  • Employees
  • 94,066
Employees
  • Stock Symbol
  • GSK
Stock Symbol
  • Investments
  • 122
  • Share Price
  • $18.49
  • (As of Monday Closing)

GlaxoSmithKline General Information

Description

In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
LON
Primary Office
  • 980 Great West Road
  • Brentford TW8 9GS
  • England, United Kingdom
+44 020 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GlaxoSmithKline Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$18.49 $18.56 $16.60 - $21.57 $93B 5.03B 11.2M $1.48

GlaxoSmithKline Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 130,639,794 130,639,794 159,334,602 123,951,515
Revenue 43,710,502 43,710,502 43,065,107 41,098,503
EBITDA 13,005,858 13,005,858 11,948,354 9,703,572
Net Income 7,369,474 7,369,474 5,926,332 4,831,118
Total Assets 109,613,367 109,613,367 104,489,432 73,680,337
Total Debt 37,000,695 37,000,695 40,001,049 33,072,784
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GlaxoSmithKline Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GlaxoSmithKline‘s full profile, request access.

Request a free trial

GlaxoSmithKline Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields
Pharmaceuticals
Brentford, United Kingdom
94,066 As of 2020
00000000000

000000

ectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
000000000000000
New York, NY
00000 As of 0000
000000 - 000

00000000

is nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dol
000000000000000
Basel, Switzerland
000000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GlaxoSmithKline Competitors (54)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer Corporation New York, NY 00000 000000 - 000
00000000 Corporation Basel, Switzerland 000000 000000000000
00000000000 Formerly PE-Backed Cambridge, United Kingdom 00000 000 00000000 000
00000000 000000000 Venture Capital-Backed Gaithersburg, MD 0000 000.00 00000 00000 000.00
00000 & 00. Corporation Kenilworth, NJ 00000 00000000
You’re viewing 5 of 54 competitors. Get the full list »

GlaxoSmithKline Executive Team (113)

Name Title Board Seat Contact Info
Emma Walmsley Chief Executive Officer & Board Member
Brian McNamara Chief Executive Officer, GSK Consumer Healthcare
John Clarke President
Luke Miels President, Global Pharmaceuticals
Iain Mackay Chief Financial Officer & Board Member
You’re viewing 5 of 113 executive team members. Get the full list »

GlaxoSmithKline Board Members (22)

Name Representing Role Since
0000000 00000000 GlaxoSmithKline Board Member 000 0000
0000 00000000 GlaxoSmithKline Chief Executive Officer & Board Member 000 0000
000 000000 GlaxoSmithKline Chief Scientific Officer & President, Research & Development 000 0000
0. 000000 00000 00 Self Board Member, Investment Board 000 0000
0000 000000 GlaxoSmithKline Chief Financial Officer & Board Member 000 0000
You’re viewing 5 of 22 board members. Get the full list »

GlaxoSmithKline Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlaxoSmithKline Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GlaxoSmithKline‘s full profile, request access.

Request a free trial

GlaxoSmithKline Investments & Acquisitions (122)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 18-Dec-2020 00000 00000 00 Drug Discovery 0000 0000
000000 00000000000 03-Aug-2020 0000 0000 Drug Discovery
0000000 21-Jul-2020 00000 00000 00 00000 Drug Discovery
00000 0000000 (000 14-Apr-2020 00000 0000000 Drug Discovery 0000 00000000
Sitari Pharmaceuticals 01-Sep-2019 Merger/Acquisition Other Pharmaceuticals and Biotechnology
You’re viewing 5 of 122 investments and acquisitions. Get the full list »

GlaxoSmithKline Subsidiaries (9)

Company Name Industry Location Founded
Action Potential Venture Capital Corporate Venture Capital Cambridge, MA 2013
000000 Pharmaceuticals Waltham, MA 0000
00000 00 0000000 0 Corporate Pension Rixensart, Belgium 0000
0000000000 Drug Discovery Schlieren, Switzerland 0000
00 000 Corporate Venture Capital Philadelphia, PA 0000
You’re viewing 5 of 9 subsidiaries. Get the full list »

GlaxoSmithKline Exits (51)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000000 000000 29-Mar-2019 00000 00000 00 00000 Completed
  • 15 buyers
000000000 00000000 14-Sep-2018 000 00000 Completed
  • 000000000000000
00000 0000000 (000 01-Jun-2018 000000000 00000000 0000 Completed
  • 000000000000000
0000000 0000000000 12-Apr-2018 000000000 Completed
  • 000000000000000
Liquidia Technologies 20-Feb-2018 Later Stage VC 000.00 Completed
  • 10 buyers
You’re viewing 5 of 51 exits. Get the full list »